134 related articles for article (PubMed ID: 37823782)
1. Efficacy and Toxicity of Calcitonin Treatment in Children with Cherubism: A Single-Center Cohort Study.
Schreuder WH; Meijer EB; Cleven AHG; Edelenbos E; Klop C; Schreurs R; de Jong RT; van Maarle MC; Horsthuis RBG; de Lange J; van den Berg H
J Bone Miner Res; 2023 Dec; 38(12):1822-1833. PubMed ID: 37823782
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism.
Kawamura H; Watanabe S; I T; Asahina I; Moriuchi H; Dateki S
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):963-966. PubMed ID: 32649295
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Study of the cell biology and biochemistry of cherubism.
Southgate J; Sarma U; Townend JV; Barron J; Flanagan AM
J Clin Pathol; 1998 Nov; 51(11):831-7. PubMed ID: 10193324
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cherubism with salmon calcitonin: a case report.
Etoz OA; Dolanmaz D; Gunhan O
Eur J Dent; 2011 Aug; 5(4):486-91. PubMed ID: 21912506
[TBL] [Abstract][Full Text] [Related]
6. Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases.
Upfill-Brown A; Bukata S; Bernthal NM; Felsenfeld AL; Nelson SD; Singh A; Wesseling-Perry K; Eilber FC; Federman NC
JBMR Plus; 2019 Oct; 3(10):e10210. PubMed ID: 31687646
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
[TBL] [Abstract][Full Text] [Related]
8. [Man with cherubism].
Hart W; Schweitzer DH; Slootweg PJ; Grootenhuis LS
Ned Tijdschr Geneeskd; 2000 Jan; 144(1):34-8. PubMed ID: 10665301
[TBL] [Abstract][Full Text] [Related]
9. Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice.
Kittaka M; Yoshimoto T; Schlosser C; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
JBMR Plus; 2020 Jun; 4(6):e10352. PubMed ID: 32537546
[TBL] [Abstract][Full Text] [Related]
10. Cherubism treated with calcitonin: report of a case.
de Lange J; van den Akker HP; Scholtemeijer M
J Oral Maxillofac Surg; 2007 Aug; 65(8):1665-7. PubMed ID: 17656300
[No Abstract] [Full Text] [Related]
11. Treatment of Progressive Cherubism during the Second Dental Transitional Phase with Calcitonin.
Meijer E; van den Berg H; Cleven AHG; Edelenbos E; Schreuder WH
Case Rep Dent; 2023; 2023():2347855. PubMed ID: 38020961
[TBL] [Abstract][Full Text] [Related]
12. Tlr2/4-Mediated Hyperinflammation Promotes Cherubism-Like Jawbone Expansion in Sh3bp2 (P416R) Knockin Mice.
Fujii Y; Monteiro N; Sah SK; Javaheri H; Ueki Y; Fan Z; Reichenberger EJ; Chen IP
JBMR Plus; 2022 Jan; 6(1):e10562. PubMed ID: 35079675
[TBL] [Abstract][Full Text] [Related]
13. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
14. Craniofacial and Dental Features in Six Children With Cherubism.
Stoor P; Suomalainen A; Kemola W; Arte S
J Craniofac Surg; 2017 Oct; 28(7):1806-1811. PubMed ID: 28857986
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological management of cherubism: A systematic review.
Cailleaux PE; Porporatti AL; Cohen-Solal M; Kadlub N; Coudert AE
Front Endocrinol (Lausanne); 2023; 14():1104025. PubMed ID: 36998472
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism.
Kadlub N; Vazquez MP; Galmiche L; L'Herminé AC; Dainese L; Ulinski T; Fauroux B; Pavlov I; Badoual C; Marlin S; Deckert M; Leboulanger N; Berdal A; Descroix V; Picard A; Coudert AE
J Bone Miner Res; 2015 May; 30(5):878-85. PubMed ID: 25491283
[TBL] [Abstract][Full Text] [Related]
18. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
[TBL] [Abstract][Full Text] [Related]
19. Two-stage surgical treatment of severe cherubism.
Raposo-Amaral CE; de Campos Guidi M; Warren SM; Almeida AB; Amstalden EM; Tiziane V; Raposo-Amaral CM
Ann Plast Surg; 2007 Jun; 58(6):645-51. PubMed ID: 17522488
[TBL] [Abstract][Full Text] [Related]
20. Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model.
Mukai T; Akagi T; Hiramatsu Asano S; Tosa I; Ono M; Kittaka M; Ueki Y; Yahagi A; Iseki M; Oohashi T; Ishihara K; Morita Y
Oral Dis; 2023 Apr; 29(3):1089-1101. PubMed ID: 34743383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
